|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics for Hispanics/Latinos, 2012. CA Cancer J Clin.
62:283–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
3
|
Serrano B, Alemany L, Ruiz PA, Tous S,
Lima MA, Bruni L, Jain A, Clifford GM, Qiao YL, Weiss T, et al:
Potential impact of a 9-valent HPV vaccine in HPV-related cervical
disease in 4 emerging countries (Brazil, Mexico, India and China).
Cancer Epidemiol. 38:748–756. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Landoni F, Maneo A, Colombo A, Placa F,
Milani R, Perego P, Favini G, Ferri L and Mangioni C: Randomised
study of radical surgery versus radiotherapy for stage Ib-IIa
cervical cancer. Lancet. 350:535–540. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Quinn MA, Benedet JL, Odicino F,
Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY and
Pecorelli S: Carcinoma of the cervix uteri. FIGO 26th Annual Report
on the Results of Treatment in Gynecological Cancer. Int J Gynaecol
Obstet. 95(Suppl 1): S43–S103. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: microRNAs in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suzuki H, Maruyama R, Yamamoto E and Kai
M: Epigenetic alteration and microRNA dysregulation in cancer.
Front Genet. 4:2582013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Friedman RC, Farh KKH, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar :
|
|
9
|
Ma R, Jiang T and Kang X: Circulating
microRNAs in cancer: Origin, function and application. J Exp Clin
Cancer Res. 31:382012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
11
|
Iorio MV and Croce CM: Causes and
consequences of microRNA dysregulation. Cancer J. 18:215–222. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Agarwal SM, Raghav D, Singh H and Raghava
GPS: CCDB: A curated database of genes involved in cervix cancer.
Nucleic Acids Res. 39:D975–D979. 2011. View Article : Google Scholar :
|
|
14
|
Juan L, Tong HL, Zhang P, Guo G, Wang Z,
Wen X, Dong Z and Tian YP: Identification and characterization of
novel serum microRNA candidates from deep sequencing in cervical
cancer patients. Sci Rep. 4:62772014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F,
Shen Y, Lu W, Wan X and Xie X: miR-375 is down-regulated in
squamous cervical cancer and inhibits cell migration and invasion
via targeting transcription factor SP1. Am J Pathol. 179:2580–2588.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kumar MS, Lu J, Mercer KL, Golub TR and
Jacks T: Impaired microRNA processing enhances cellular
transformation and tumorigenesis. Nat Genet. 39:673–677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yao T and Lin Z: MiR-21 is involved in
cervical squamous cell tumorigenesis and regulates CCL20. Biochim
Biophys Acta. 1822:248–260. 2012. View Article : Google Scholar
|
|
18
|
Pang RTK, Leung CON, Ye TM, Liu W, Chiu
PC, Lam KK, Lee KF and Yeung WS: MicroRNA-34a suppresses invasion
through downregulation of Notch1 and Jagged1 in cervical carcinoma
and choriocarcinoma cells. Carcinogenesis. 31:1037–1044. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li JH, Xiao X, Zhang YN, Wang YM, Feng LM,
Wu YM and Zhang YX: MicroRNA miR-886-5p inhibits apoptosis by
down-regulating Bax expression in human cervical carcinoma cells.
Gynecol Oncol. 120:145–151. 2011. View Article : Google Scholar
|
|
20
|
Liu L, Yu X, Guo X, Tian Z, Su M, Long Y,
Huang C, Zhou F, Liu M, Wu X, et al: miR-143 is downregulated in
cervical cancer and promotes apoptosis and inhibits tumor formation
by targeting Bcl-2. Mol Med Rep. 5:753–760. 2012.
|
|
21
|
Zhu X, Er K, Mao C, Yan Q, Xu H, Zhang Y,
Zhu J, Cui F, Zhao W and Shi H: miR-203 suppresses tumor growth and
angiogenesis by targeting VEGFA in cervical cancer. Cell Physiol
Biochem. 32:64–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lao G, Liu P, Wu Q, Zhang W, Liu Y, Yang L
and Ma C: Mir-155 promotes cervical cancer cell proliferation
through suppression of its target gene LKB1. Tumour Biol.
35:11933–11939. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pereira PM, Marques JP, Soares AR, Carreto
L and Santos MA: MicroRNA expression variability in human cervical
tissues. PLoS One. 5:e117802010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li BH, Zhou JS, Ye F, Cheng XD, Zhou CY,
Lu WG and Xie X: Reduced miR-100 expression in cervical cancer and
precursors and its carcinogenic effect through targeting PLK1
protein. Eur J Cancer. 47:2166–2174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J,
Lu W, Wan X, Ma D and Xie X: Progressive miRNA expression profiles
in cervical carcinogenesis and identification of HPV-related target
genes for miR-29. J Pathol. 224:484–495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang X, Meyers C, Guo M and Zheng ZM:
Upregulation of p18Ink4c expression by oncogenic HPV E6 via
p53-miR-34a pathway. Int J Cancer. 129:1362–1372. 2011. View Article : Google Scholar :
|
|
27
|
Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ,
Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, et al: Altered MicroRNA
expression in cervical carcinomas. Clin Cancer Res. 14:2535–2542.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chemoradiotherapy for Cervical Cancer
Meta-Analysis Collaboration: Reducing uncertainties about the
effects of chemoradiotherapy for cervical cancer: A systematic
review and meta-analysis of individual patient data from 18
randomized trials. J Clin Oncol. 26:5802–5812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu X, Schwarz JK, Lewis JS Jr, Huettner
PC, Rader JS, Deasy JO, Grigsby PW and Wang X: A microRNA
expression signature for cervical cancer prognosis. Cancer Res.
70:1441–1448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang L, Lin JX, Yu YH, Zhang MY, Wang HY
and Zheng M: Downregulation of six microRNAs is associated with
advanced stage, lymph node metastasis and poor prognosis in small
cell carcinoma of the cervix. PLoS One. 7:e337622012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shen SN, Wang LF, Jia YF, Hao YQ, Zhang L
and Wang H: Upregulation of microRNA-224 is associated with
aggressive progression and poor prognosis in human cervical cancer.
Diagn Pathol. 8:692013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang L, Wang Q, Li HL and Han LY:
Expression of MiR200a, miR93, metastasis-related gene RECK and
MMP2/MMP9 in human cervical carcinoma - relationship with
prognosis. Asian Pac J Cancer Prev. 14:2113–2118. 2013. View Article : Google Scholar
|
|
33
|
Wang N, Zhou Y, Zheng L and Li H: MiR-31
is an independent prognostic factor and functions as an oncomir in
cervical cancer via targeting ARID1A. Gynecol Oncol. 134:129–137.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu A, Huang JJ, Xu WH, Jin XJ, Li JP, Tang
YJ, Huang XF, Cui HJ and Sun GB: miR-21 and miR-375 microRNAs as
candidate diagnostic biomarkers in squamous cell carcinoma of the
larynx: Association with patient survival. Am J Transl Res.
6:604–613. 2014.PubMed/NCBI
|
|
35
|
Miller P, Clarke J, Koru-Sengul T,
Brinkman J and El-Ashry D: A novel MAPK-microRNA signature is
predictive of hormone-therapy resistance and poor outcome in
ER-positive breast cancer. Clin Cancer Res. 21:373–385. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shi M, Du L, Liu D, Qian L, Hu M, Yu M,
Yang Z, Zhao M, Chen C, Guo L, et al: Glucocorticoid regulation of
a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy
resistance of cervical cancer cells. J Pathol. 228:148–157. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang F, Liu M, Li X and Tang H: MiR-214
reduces cell survival and enhances cisplatin-induced cytotoxicity
via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett.
587:488–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang B, Chen J, Ren Z, Chen Y, Li J, Miao
X, Song Y, Zhao T, Li Y, Shi Y, et al: A specific miRNA signature
promotes radioresistance of human cervical cancer cells. Cancer
Cell Int. 13:1182013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ke G, Liang L, Yang JM, Huang X, Han D,
Huang S, Zhao Y, Zha R, He X and Wu X: MiR-181a confers resistance
of cervical cancer to radiation therapy through targeting the
pro-apoptotic PRKCD gene. Oncogene. 32:3019–3027. 2013. View Article : Google Scholar
|
|
40
|
Chen Y, Ke G, Han D, Liang S, Yang G and
Wu X: MicroRNA-181a enhances the chemoresistance of human cervical
squamous cell carcinoma to cisplatin by targeting PRKCD. Exp Cell
Res. 320:12–20. 2014. View Article : Google Scholar
|
|
41
|
Fang L, Li H, Wang L, Hu J, Jin T, Wang J
and Yang BB: MicroRNA-17-5p promotes chemotherapeutic drug
resistance and tumour metastasis of colorectal cancer by repressing
PTEN expression. Oncotarget. 5:2974–2987. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lee KM, Choi EJ and Kim IA: microRNA-7
increases radiosen-sitivity of human cancer cells with activated
EGFR-associated signaling. Radiother Oncol. 101:171–176. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang SM, Huang C, Li XF, Yu MZ, He Y and
Li J: miR-21 confers cisplatin resistance in gastric cancer cells
by regulating PTEN. Toxicology. 306:162–168. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xie H, Lee L, Scicluna P, Kavak E, Larsson
C, Sandberg R and Lui WO: Novel functions and targets of miR-944 in
human cervical cancer cells. Int J Cancer. 136:E230–E241. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Villegas-Ruiz V, Juárez-Méndez S,
Pérez-González OA, Arreola H, Paniagua-García L, Parra-Melquiadez
M, Peralta-Rodríguez R, López-Romero R, Monroy-García A,
Mantilla-Morales A, et al: Heterogeneity of microRNAs expression in
cervical cancer cells: Over-expression of miR-196a. Int J Clin Exp
Pathol. 7:1389–1401. 2014.PubMed/NCBI
|
|
46
|
Luo M, Shen D, Zhou X, Chen X and Wang W:
MicroRNA-497 is a potential prognostic marker in human cervical
cancer and functions as a tumor suppressor by targeting the
insulin-like growth factor 1 receptor. Surgery. 153:836–847. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
He L, Wang HY, Zhang L, Huang L, Li JD,
Xiong Y, Zhang MY, Jia WH, Yun JP, Luo RZ, et al: Prognostic
significance of low DICER expression regulated by miR-130a in
cervical cancer. Cell Death Dis. 5:e12052014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lei C, Wang Y, Huang Y, Yu H, Huang Y, Wu
L and Huang L: Up-regulated miR155 reverses the
epithelial-mesenchymal transition induced by EGF and increases
chemo-sensitivity to cisplatin in human Caski cervical cancer
cells. PLoS One. 7:e523102012. View Article : Google Scholar
|
|
49
|
Liang H, Li Y, Luo RY and Shen FJ:
MicroRNA-215 is a potential prognostic marker for cervical cancer.
J Huazhong Univ Sci Technolog Med Sci. 34:207–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cai N, Wang YD and Zheng PS: The
microRNA-302-367 cluster suppresses the proliferation of cervical
carcinoma cells through the novel target AKT1. RNA. 19:85–95. 2013.
View Article : Google Scholar :
|
|
51
|
Wang L, Chang L, Li Z, Gao Q, Cai D, Tian
Y, Zeng L and Li M: miR-99a and -99b inhibit cervical cancer cell
proliferation and invasion by targeting mTOR signaling pathway. Med
Oncol. 31:9342014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Xu J, Li Y, Wang F, Wang X, Cheng B, Ye F,
Xie X, Zhou C and Lu W: Suppressed miR-424 expression via
upregulation of target gene Chk1 contributes to the progression of
cervical cancer. Oncogene. 32:976–987. 2013. View Article : Google Scholar
|
|
53
|
Wen SY, Lin Y, Yu YQ, Cao SJ, Zhang R,
Yang XM, Li J, Zhang YL, Wang YH, Ma MZ, et al: miR-506 acts as a
tumor suppressor by directly targeting the hedgehog pathway
transcription factor Gli3 in human cervical cancer. Oncogene.
34:717–725. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xie H, Zhao Y, Caramuta S, Larsson C and
Lui WO: miR-205 expression promotes cell proliferation and
migration of human cervical cancer cells. PLoS One. 7:e469902012.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Leung CON, Deng W, Ye T-M, Ngan HY, Tsao
SW, Cheung AN, Pang RT and Yeung WS: miR-135a leads to cervical
cancer cell transformation through regulation of β-catenin via a
SIAH1-dependent ubiquitin proteosomal pathway. Carcinogenesis.
35:1931–1940. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wei Q, Li Y-X, Liu M, Li X and Tang H:
MiR-17-5p targets TP53INP1 and regulates cell proliferation and
apoptosis of cervical cancer cells. IUBMB Life. 64:697–704. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang J, Li S, Yan Q, Chen X, Yang Y, Liu
X and Wan X: Interferon-β induced microRNA-129-5p down-regulates
HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical
cancer cells. PLoS One. 8:e813662013. View Article : Google Scholar
|
|
58
|
Long MJ, Wu FX, Li P, Liu M, Li X and Tang
H: MicroRNA-10a targets CHL1 and promotes cell growth, migration
and invasion in human cervical cancer cells. Cancer Lett.
324:186–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chu Y, Ouyang Y, Wang F, Zheng A, Bai L,
Han L, Chen Y and Wang H: MicroRNA-590 promotes cervical cancer
cell growth and invasion by targeting CHL1. J Cell Biochem.
115:847–853. 2014. View Article : Google Scholar
|
|
60
|
Xu XM, Wang XB, Chen MM, Liu T, Li YX, Jia
WH, Liu M, Li X and Tang H: MicroRNA-19a and -19b regulate cervical
carcinoma cell proliferation and invasion by targeting CUL5. Cancer
Lett. 322:148–158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Cui F, Li X, Zhu X, Huang L, Huang Y, Mao
C, Yan Q, Zhu J, Zhao W and Shi H: MiR-125b inhibits tumor growth
and promotes apoptosis of cervical cancer cells by targeting
phosphoinositide 3-kinase catalytic subunit delta. Cell Physiol
Biochem. 30:1310–1318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Xin JX, Yue Z, Zhang S, Jiang ZH, Wang PY,
Li YJ, Pang M and Xie SY: miR-99 inhibits cervical carcinoma cell
proliferation by targeting TRIB2. Oncol Lett. 6:1025–1030.
2013.PubMed/NCBI
|
|
63
|
Kang HW, Wang F, Wei Q, Zhao YF, Liu M, Li
X and Tang H: miR-20a promotes migration and invasion by regulating
TNKS2 in human cervical cancer cells. FEBS Lett. 586:897–904. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhang J, Zheng F, Yu G, Yin Y and Lu Q:
miR-196a targets netrin 4 and regulates cell proliferation and
migration of cervical cancer cells. Biochem Biophys Res Commun.
440:582–588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Peng RQ, Wan HY, Li HF, Liu M, Li X and
Tang H: MicroRNA-214 suppresses growth and invasiveness of cervical
cancer cells by targeting
UDP-N-acetyl-α-D-galactosamine:polypeptide
N-acetylgalactosaminyltransferase 7. J Biol Chem. 287:14301–14309.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wang YD, Cai N, Wu XL, Cao H-Z, Xie LL and
Zheng PS: OCT4 promotes tumorigenesis and inhibits apoptosis of
cervical cancer cells by miR-125b/BAK1 pathway. Cell Death Dis.
4:e7602013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Qin W, Dong P, Ma C, Mitchelson K, Deng T,
Zhang L, Sun Y, Feng X, Ding Y, Lu X, et al: MicroRNA-133b is a key
promoter of cervical carcinoma development through the activation
of the ERK and AKT1 pathways. Oncogene. 31:4067–4075. 2012.
View Article : Google Scholar
|
|
68
|
How C, Hui ABY, Alajez NM, Shi W, Boutros
PC, Clarke BA, Yan R, Pintilie M, Fyles A, Hedley DW, et al:
MicroRNA-196b regulates the homeobox B7-vascular endothelial growth
factor axis in cervical cancer. PLoS One. 8:e678462013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Liu S, Zhang P, Chen Z, Liu M, Li X and
Tang H: MicroRNA-7 downregulates XIAP expression to suppress cell
growth and promote apoptosis in cervical cancer cells. FEBS Lett.
587:2247–2253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yamamoto N, Kinoshita T, Nohata N, Itesako
T, Yoshino H, Enokida H, Nakagawa M, Shozu M and Seki N: Tumor
suppressive microRNA-218 inhibits cancer cell migration and
invasion by targeting focal adhesion pathways in cervical squamous
cell carcinoma. Int J Oncol. 42:1523–1532. 2013.PubMed/NCBI
|
|
71
|
Tian RQ, Wang XH, Hou LJ, Jia WH, Yang Q,
Li YX, Liu M, Li X and Tang H: MicroRNA-372 is down-regulated and
targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human
cervical cancer, which may contribute to tumorigenesis. J Biol
Chem. 286:25556–25563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Au Yeung CL, Tsang TY, Yau PL and Kwok TT:
Human papillomavirus type 16 E6 induces cervical cancer cell
migration through the p53/microRNA-23b/urokinase-type plasminogen
activator pathway. Oncogene. 30:2401–2410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Abdelmohsen K, Kim MM, Srikantan S,
Mercken EM, Brennan SE, Wilson GM, Cabo R and Gorospe M: miR-519
suppresses tumor growth by reducing HuR levels. Cell Cycle.
9:1354–1359. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Qiang R, Wang F, Shi LY, Liu M, Chen S,
Wan HY, Li YX, Li X, Gao SY and Sun BC: Plexin-B1 is a target of
miR-214 in cervical cancer and promotes the growth and invasion of
HeLa cells. Int J Biochem Cell Biol. 43:632–641. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Yao Q, Xu H, Zhang QQ, Zhou H and Qu LH:
MicroRNA-21 promotes cell proliferation and down-regulates the
expression of programmed cell death 4 (PDCD4) in HeLa cervical
carcinoma cells. Biochem Biophys Res Commun. 388:539–542. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Li B, Hu Y, Ye F, Li Y, Lv W and Xie X:
Reduced miR-34a expression in normal cervical tissues and cervical
lesions with high-risk human papillomavirus infection. Int J
Gynecol Cancer. 20:597–604. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar :
|
|
78
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Melar-New M and Laimins LA: Human
papillomaviruses modulate expression of microRNA 203 upon
epithelial differentiation to control levels of p63 proteins. J
Virol. 84:5212–5221. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Dong J, Sui L, Wang Q, Chen M and Sun H:
MicroRNA-26a inhibits cell proliferation and invasion of cervical
cancer cells by targeting protein tyrosine phosphatase type IVA 1.
Mol Med Rep. 10:1426–1432. 2014.PubMed/NCBI
|
